Today: 16 April 2026
Charles Schwab stock steadies in premarket after AI tax-tool jitters slam shares 7%
11 February 2026
1 min read

Charles Schwab stock steadies in premarket after AI tax-tool jitters slam shares 7%

New York, Feb 11, 2026, 05:04 EST — Premarket

The Charles Schwab Corporation saw its shares edge up roughly 0.3% to $99.53 before the bell on Wednesday. On Tuesday, the stock had slipped 7.42%, ending the session at $99.25.

After Altruist rolled out AI-powered tax-planning tools, shares of U.S. brokerages tumbled. The 2018-founded wealth-tech startup, which operates a self-clearing platform for investment advisers, says its new feature digests client documents to automate tailored tax strategies—fueling fears that automation will erode advisory fees. LPL Financial and Raymond James each slid over 8% Tuesday; Ameriprise dropped 6.2%. “Traders sell first and ask questions later,” summed up Dennis Dick, chief market strategist at Stock Trader Network. Reuters

“Uncertainty is really high and it’s very hard to kind of disprove a negative,” UBS analyst Michael Brown said. Over at Bloomberg Intelligence, Neil Sipes flagged investor worries around “fee compression”—basically, tighter advisory pricing—and the possibility of market-share shifts. Wilma Burdis of Raymond James, though, called the recent selloff “completely overblown,” arguing clients still prefer having a human in charge of their money. Wealth Management

Tax work has long been lucrative for wealth managers—proximity to trust, judgment, and accountability keeps it that way. But when investors suspect software can handle more of the job at a lower cost, they often squeeze margins from these stocks first.

Schwab shares kicked off Tuesday at $107.00 and briefly touched $107.50 before tumbling to a session low of $97.01. The stock settled at $99.25, historical pricing data show. More than 40 million shares changed hands.

Schwab shares had just finished up at $107.21, notching a fresh 52-week high after rallying for two straight sessions, according to MarketWatch data. Now, with that sharp reversal, traders are zeroed in on the whiplash move at the open.

Schwab’s co-chairman Walter Bettinger exercised options and offloaded 67,514 shares on Feb. 6 at an average of roughly $104.25 apiece, according to a filing posted Tuesday. The transaction totaled around $7.0 million.

Still, markets haven’t settled on a clear view of AI yet, and sentiment can shift quickly. Should investors start to believe tax planning and advice-focused services face ongoing price squeezes, brokerages might continue to slide—regardless of whether immediate impact shows up.

The regular session will tell the story: can Schwab stay within its range after the drop, or does the AI theme spark fresh selling across the sector?

Schwab announced back in late January it’s set to pay out a $0.32 per share quarterly dividend on Feb. 27, with the cutoff for shareholders of record falling on Feb. 13. Dividend-focused investors are circling that date through the week.

Stock Market Today

  • Braze (BRZE) Share Price Rebound Prompts Valuation Review After Mixed Returns
    April 15, 2026, 10:53 PM EDT. Braze's stock gained 5.9% last week and 19.9% over the past month but remains down 20% over one year, reflecting investor caution amid debates on growth and profitability. A Discounted Cash Flow (DCF) analysis, which estimates intrinsic value by forecasting future cash generation, values Braze at $35.86 per share, suggesting the stock is undervalued by about 36.6%. The company's free cash flow is projected to rise from $53.5 million to $220.6 million by 2031. Given its valuation score of 5 out of 6, Braze stays on the radar of investors eyeing quality growth stocks with improving financial metrics. However, profitability consistency and market risks continue to influence how the stock is priced relative to revenue multiples.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up
Previous Story

London Stock Exchange Group (LSEG) share price jumps on Elliott stake report as buyback debate flares up

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive
Next Story

Quince Therapeutics (QNCX) stock price jumps in premarket as strategic review keeps deal talk alive

Go toTop